Siddhartha Mitra

Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death

Montserrat Arrasate, Siddhartha Mitra, Erik S. Schweitzer et al. · Nature · 2004 · 2K citations

Life Sciences, Neurobiology, Neuroscience +15

A phase 2 study of idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemia

Susan O’Brien, Nicole Lamanna, Thomas J. Kipps et al. · Blood · 2015 · 240 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +9

Identifying polyglutamine protein species in situ that best predict neurodegeneration

Jason Miller, Montserrat Arrasate, Elizabeth D. Brooks et al. · Nature Chemical Biology · 2011 · 222 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +14

Final Results of a Randomized, Phase III Study of Rituximab With or Without Idelalisib Followed by Open-Label Idelalisib in Patients With Relapsed Chronic Lymphocytic Leukemia

Jeff P. Sharman, Steven Coutré, Richard R. Furman et al. · Journal of Clinical Oncology · 2019 · 221 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

AMPA receptors regulate transcription of the plasticity-related immediate-early gene Arc

Vikram R. Rao, Sean A. Pintchovski, Jeannie Chin et al. · Nature Neuroscience · 2006 · 192 citations

Life Sciences, Molecular Biology, Neuroscience +14